A Phase I Study of KLA318-2 Nanocrystal Injection

NCT07171034 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: KLA318-2 Nanocrystal Injection
DRUG: Celebrex Capsule

Sponsor

Hunan Kelun Pharmaceutical Co., Ltd.